Tamura, Y.;                     Ito, A.;                     Wakamatsu, K.;                     Torigoe, T.;                     Honda, H.;                     Ito, S.;                     Jimbow, K.    
        A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma. Int. J. Mol. Sci. 2023, 24, 5235.
    https://doi.org/10.3390/ijms24065235
    AMA Style
    
                                Tamura Y,                                 Ito A,                                 Wakamatsu K,                                 Torigoe T,                                 Honda H,                                 Ito S,                                 Jimbow K.        
                A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma. International Journal of Molecular Sciences. 2023; 24(6):5235.
        https://doi.org/10.3390/ijms24065235
    
    Chicago/Turabian Style
    
                                Tamura, Yasuaki,                                 Akira Ito,                                 Kazumasa Wakamatsu,                                 Toshihiko Torigoe,                                 Hiroyuki Honda,                                 Shosuke Ito,                                 and Kowichi Jimbow.        
                2023. "A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma" International Journal of Molecular Sciences 24, no. 6: 5235.
        https://doi.org/10.3390/ijms24065235
    
    APA Style
    
                                Tamura, Y.,                                 Ito, A.,                                 Wakamatsu, K.,                                 Torigoe, T.,                                 Honda, H.,                                 Ito, S.,                                 & Jimbow, K.        
        
        (2023). A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma. International Journal of Molecular Sciences, 24(6), 5235.
        https://doi.org/10.3390/ijms24065235